Kusuri Context Studio
Back to articles

病院でもらう薬、一部に追加負担。2027年3月1日から何が変わる?

Extra Charges for Some Medicines from Your Doctor: What Changes on March 1, 2027?

Read the original
病院でもらう薬、一部に追加負担。2027年3月1日から何が変わる?

いつもの処方薬に、来年から追加の料金がかかる。気になるのは、「自分の薬代はいくら変わるのか」だと思います。

An additional charge will apply to your usual prescription medicine starting next year. You are probably wondering, “How much will my own medicine costs change?”

2027年3月1日から、市販薬との代替性が特に高い一部の処方薬に、薬剤費の4分の1の別途負担が始まります。9月30日の政令と厚生労働省の通知で、開始日と実施の扱いが定まりました。厚生労働省の制度案内に、通知と対象薬のリストが掲載されています。

From March 1, 2027, a separate patient charge equal to one-quarter of the drug cost will apply to some prescription medicines with particularly close OTC substitutes. The September 30 Cabinet Order and Ministry of Health, Labour and Welfare notice established the start date and implementation details. The notice and list of affected medicines are published on the ministry's information page about the system.

ただし、病院の薬がすべて対象になるわけでも、対象の薬が全額自己負担になるわけでもありません。同じ薬でも、使う目的や治療の事情によって、追加負担がかからない場合があります。

However, this does not apply to every medicine prescribed at a hospital, nor does it mean affected medicines become entirely self-paid. Even for the same medicine, the additional charge may not apply depending on its purpose and the circumstances of treatment.

ディレグラ14日分なら、薬代部分は約220円増える例

An example: About ¥220 more for the medicine portion of a 14-day supply of Dellegra

まず、「薬の金額」と「自分が払う金額」を分けてみます。医療用の薬には、国が定める単位当たりの価格「薬価」があります。薬価に数量を掛けた薬全体の金額を、保険と患者で分担します。窓口では、それに診察や調剤などの費用も加わります。

First, let us separate “the cost of the medicine” from “the amount you pay.” Prescription medicines have a government-set price per unit, called the drug tariff price. The total drug cost, calculated by multiplying that price by the quantity, is shared between insurance and the patient. At the counter, consultation and dispensing fees are added too.

今回は、アレルギー性鼻炎に使うディレグラ配合錠の一例です。添付文書の成人の通常用量は1回2錠、1日2回。14日分なら56錠です。現行薬価は1錠24.7円なので、薬全体の金額は約1,383円になります。

Here is one example involving Dellegra Combination Tablets, used for allergic rhinitis. The usual adult dosage in the package insert is two tablets twice a day. A 14-day supply is therefore 56 tablets. At the current drug tariff price of ¥24.7 per tablet, the total drug cost is about ¥1,383.

ここから、成人が薬局で調剤を受ける外来処方、3割負担、追加負担の対象外条件に該当しない場合を考えます。この薬だけの薬代を精算し、現在の別途料金がない条件で比べたモデルです。

The following model assumes an adult outpatient whose prescription is dispensed at a pharmacy, with a 30% copayment and no conditions that exempt them from the additional charge. It calculates the medicine portion for this drug alone and compares it with the current arrangement assuming no existing separate charge.

画像
Image
  • 現在:保険の3割負担で、薬代部分は約420円。

  • 見直し後:保険部分の3割負担約290円+特別の料金約350円=約640円。

  • この条件での差:約220円増。

  • Currently: With a 30% insurance copayment, the medicine portion is about ¥420.

  • After the change: About ¥290 as the 30% copayment on the insured portion + about ¥350 as the special charge = about ¥640.

  • Difference under these conditions: An increase of about ¥220.

では、290円と350円はどう計算するのでしょうか。この例は、ディレグラを1日4錠、14日分(56錠)使う場合です。まず、1錠24.70円を「特別の料金になる分」と「保険が使われる分」に分けます。

How are the ¥290 and ¥350 calculated? This example assumes four Dellegra tablets per day for 14 days, totaling 56 tablets. First, the ¥24.70 per tablet is divided into the portion subject to the “special charge” and the portion covered by insurance.

  • 特別の料金:約4分の1の6.18円×56錠=346.08円。10円単位に丸めて約350円です。

  • 保険が使われる分:残りの18.52円×1日4錠=74.08円。医療費の計算ルールでは、これを1日7点(70円)として計算します。70円×14日=980円の3割は294円。10円単位に丸めると約290円です。

  • Special charge: Approximately one-quarter, ¥6.18, × 56 tablets = ¥346.08. Rounded to the nearest ¥10, this is about ¥350.

  • Insured portion: The remaining ¥18.52 × four tablets per day = ¥74.08. Under medical fee calculation rules, this is calculated as seven points (¥70) per day. ¥70 × 14 days = ¥980, of which 30% is ¥294. Rounded to the nearest ¥10, this is about ¥290.

つまり、今の420円に350円をそのまま足すのではなく、保険部分の約290円と特別の料金の約350円を合わせて、約640円になります。

In other words, you do not simply add ¥350 to the current ¥420. You combine about ¥290 for the insured portion with about ¥350 as the special charge, giving about ¥640.

これは、点数換算と端数処理を入れ、この薬だけで精算する場合の薬代部分の試算です。実際はほかの薬や調剤料などと合算するため、窓口の金額は異なる場合があります。消費税は含めていません。税の取扱いは9月30日付通知では未確定です。今後の薬価改定でも金額は変わります。

This estimate of the medicine portion includes conversion into points and rounding, assuming this drug is settled on its own. Actual amounts paid at the counter may differ because other medicines and dispensing fees are combined. Consumption tax is not included. Tax treatment remained undecided in the September 30 notice. Future drug tariff revisions will also change the amounts.

14日分は比較のための数量で、処方や服用期間の推奨ではありません。ディレグラは鼻づまりが中等症以上の場合に使用を検討し、強い期間の最小限の使用にとどめる薬です。2週間を超える使用の有効性・安全性は臨床試験で検討されていません。

The 14-day quantity is used for comparison; it is not a recommendation for a prescription or treatment duration. Dellegra should be considered when nasal congestion is moderate or severe, and use should be limited to the shortest period during which congestion is severe. Efficacy and safety for use beyond two weeks have not been studied in clinical trials.

薬名だけでは、追加負担は決まらない

The medicine's name alone does not determine the additional charge

対象リストに載った薬でも、その人の処方が必ず追加負担になるとは限りません。市販薬の効能・効果で対応できる状態なのか、医療用の薬が必要な事情があるかを確認します。

Even if a medicine is on the list, a person's prescription will not necessarily attract the additional charge. The assessment considers whether the condition falls within the OTC medicine's indications and whether there are circumstances requiring a prescription medicine.

たとえば、フェキソフェナジンは鼻のアレルギー症状に使う場合と、じんましんなど皮膚の症状に使う場合で扱いが異なります。成分が同じでも、何のための処方かが関係するのです。

For example, fexofenadine is treated differently when used for nasal allergy symptoms and when used for skin symptoms such as hives. Even with the same ingredient, the reason for the prescription matters.

通知で示された対象外の条件には、次のようなものがあります。

The notice identifies exemption conditions such as the following.

  • 子ども:18歳に達した日以後の最初の3月31日まで。

  • がん・指定難病等の治療に関連する使用や、通知に該当する国の公費負担医療、入院時の処方〔退院時処方を含む〕。

  • 検査・処置・手術に伴う処方で、同日の新規処方や14日以内分など、通知の条件を満たす場合。

  • 年間を通じた長期使用が医療上必要で、薬の種類ごとの基準を満たす場合。

  • 市販薬では対応できない状態や、妊婦・授乳婦等が特定の対象薬を使う場合。

  • Children: Through the first March 31 on or after their 18th birthday.

  • Use related to treatment for cancer, designated intractable diseases, and similar conditions; nationally funded medical care covered by the notice; and prescriptions during hospitalization, including discharge prescriptions.

  • Prescriptions associated with tests, procedures, or surgery that meet the notice's conditions, such as new prescriptions on the same day or supplies of no more than 14 days.

  • Cases where long-term, year-round use is medically necessary and the criteria for the medicine category are met.

  • Conditions that OTC medicines cannot address, or use of certain affected medicines by pregnant or breastfeeding women and others specified.

病名がある、所得が低い、妊娠中である、長く使っている、といった事情だけで、すべての薬が一律に対象外になるわけではありません。処方時に医師が基準に沿って判断します。

Having a diagnosis, a low income, being pregnant, or using a medicine for a long time does not automatically exempt every medicine. The prescribing doctor decides according to the criteria.

長期使用の内服薬には、おおむね年間50週という基準があります。一方、半年間の使用継続を確認し、今後も通年の使用が必要と医師が認めれば、対象外と判断できる場合があります。塗り薬も、アトピー性皮膚炎の再燃を防ぐ計画的な治療など、使い方と継続性の条件を確認します。「半年使えば免除」「塗り薬なら免除」という意味ではありません。

For long-term oral medicines, one criterion is use for roughly 50 weeks a year. However, an exemption may be possible after six months of continued use has been confirmed, if a doctor recognizes that year-round use will remain necessary. Topical medicines also require checking conditions concerning how they are used and continuity of use, such as planned treatment to prevent atopic dermatitis flare-ups. This does not mean “exempt after six months” or “exempt if it is a topical medicine.”

約220円増えたら、市販薬へ移った方が得なのか

If the increase is about ¥220, is switching to an OTC medicine better value?

追加負担が増えることと、市販薬へ切り替えた方が得になることは、同じではありません。

An increase in the additional charge does not necessarily mean switching to an OTC medicine is better value.

ほかの病気のためにも通院している人は、この薬を市販薬に置き換えても、診察料や通院時間がそのままなくなるとは限りません。主に比べるのは、処方薬の負担、市販薬の購入費、そして実際に減る費用です。

For someone who also attends medical appointments for other conditions, replacing this medicine with an OTC product does not necessarily eliminate consultation fees or time spent attending appointments. The main comparison is between the prescription copayment, the OTC purchase cost, and the expenses that would actually decrease.

その薬だけのために受診している人なら、診察・処方・薬局の費用や、移動・待ち時間も比較に関係します。ただし、受診が必要か、市販薬で対応できる状態かは金額だけでは決められません。

For someone attending appointments solely for this medicine, consultation, prescription, and pharmacy costs, as well as travel and waiting time, also matter. However, whether medical attention is necessary and whether an OTC medicine can address the condition cannot be decided on cost alone.

今回は、市販薬の実売価格を同じ数量・使用期間で比較していません。「市販薬の方が何円安い」「何割の人が切り替える」という結論は出せません。私は、約220円の差だけで行動が決まると考えるのは早いと思います。薬の適否や治療の続けやすさも含めて考えたいところです。

This article does not compare actual OTC retail prices for the same quantity and duration of use. It cannot conclude that “the OTC medicine is ¥X cheaper” or that “X% of people will switch.” I think it is too early to assume that a difference of about ¥220 alone determines behavior. We should also consider whether the medicine is appropriate and how easy it is to continue treatment.

保険の支出が減る一方、患者の負担は増える

Insurance spending decreases while the patient's burden increases

厚労省は、医療保険制度の持続可能性を確保することを制度の目的に挙げています。薬の使用量や受診が変わらなくても、薬代の一部を患者が別途払えば、保険から支払う額は減る方向に働きます。

The ministry identifies securing the sustainability of the medical insurance system as a purpose of the policy. Even if medicine use and medical visits remain unchanged, a separate patient payment for part of the drug cost tends to reduce the amount paid by insurance.

これは、国の税収や医療機関の利益が増えるという話ではありません。保険給付の一部が患者負担へ移るという関係です。市販薬への切り替えが進まなくても、この財政上の変化は起こり得ます。

This does not mean increased government tax revenue or higher profits for medical institutions. It means that part of the insurance benefit shifts to the patient. This financial change can occur even without more people switching to OTC medicines.

私は、保険財政の余力を考えることと、治療を続ける患者への影響を考えることは、両方必要だと思います。費用の移し方が変わるだけで、診察や調剤に使う医療資源が自動的に減るわけではありません。減った支出が特定の医療へ回されるという使途も、今回の資料では確認できていません。

I think we need to consider both the financial capacity of the insurance system and the impact on patients continuing treatment. Changing how costs are allocated does not automatically reduce the medical resources used for consultations and dispensing. Nor could I confirm from these materials that the reduced spending is earmarked for a particular type of medical care.

自分の処方は、医師や薬局で確認する

Check your own prescription with your doctor or pharmacy

処方箋には「一部保険外療養」欄が新設され、対象の薬ごとに、追加負担の対象なら「○」、対象外なら「―」が記載されます。気になる薬は、「この目的で使う自分の処方は対象ですか」と確認できます。長く使う薬なら、お薬手帳など使用歴が分かる情報も役立ちます。他院での使用歴も確認に使えます。

A new “partially uninsured medical care” field will be added to prescriptions. Each affected medicine will be marked “○” if the additional charge applies or “―” if it does not. For a medicine you are concerned about, you can ask, “Does my prescription for this purpose fall within the additional charge?” For a medicine you use long term, a medication notebook or other information showing your history of use may help. Use at other medical institutions can also be checked.

なお、3月1日より前に処方された対象薬を、3月1日以降に薬局で調剤する場合には、施行前の扱いとなる経過措置があります。リフィルや分割指示のある処方箋の後の回の調剤も含まれます。調剤日だけで追加負担を決めないことも大切です。

There is also a transitional arrangement for affected medicines prescribed before March 1, 2027, and dispensed at a pharmacy on or after that date: the pre-implementation rules apply. This includes later dispensings under refill prescriptions and prescriptions with instructions for split dispensing. The dispensing date alone should not determine whether the additional charge applies.

通知は、対象薬の処方を控えることを意図した制度ではないとしています。自己判断で薬を止めたり置き換えたりせず、必要な治療と費用を一緒に相談する。そのために、薬名、処方の目的、治療の条件を確かめるところから始められます。

The notice states that the system is not intended to discourage prescribing the affected medicines. Rather than stopping or replacing a medicine on your own, discuss the necessary treatment and its costs together. You can start by confirming the medicine's name, why it was prescribed, and the treatment circumstances.

※2026年10月1日時点の公的資料に基づく一般的な制度解説です。金額は薬代部分のモデルで、個別の支払額・対象外の判断を確定しません。自身の処方は医療機関・薬局へご確認ください。

Note: This is a general explanation of the system based on official materials available as of October 1, 2026. The amounts are a model of the medicine portion and do not determine an individual's payment or exemption eligibility. Check your own prescription with your medical institution or pharmacy.

More from the author

Read on note, or subscribe to the Japanese and English publications on Substack.

Sharing uses the publicly accessible original article URL.

This page reproduces the published article, with subscription and sharing links adapted for this site. Figures are hosted by the original publication.
Back to articles